China Everbright Limited

Overview

China Everbright Limited is a Hong Kong-based financial services company specializing in asset management and investment. With over 27 years of experience, it is a pioneer in China's cross-border asset management industry. The company manages a diverse portfolio of funds, including private equity, venture capital, fixed income, and real estate, with assets under management totaling HK$119.4 billion as of June 30, 2025. Its investments span various sectors, such as technology, healthcare, real estate, and financial services, both within China and internationally. The company's investment strategy focuses on identifying high-growth potential enterprises and introducing advanced overseas technologies to the Chinese market. It has invested in over 300 companies, including notable names like Goldwind, BGI, Betta Pharmaceuticals, Amcare, LifeTech Scientific Corporation, Focus Media, iQIYI, SenseTime, and NIO. More than 150 of these companies have been listed in China or overseas, or have exited through mergers and acquisitions. China Everbright Limited's investment philosophy emphasizes long-term value creation and flexibility in responding to global market changes. Its international platform and specialized sector-focused teams enable it to capitalize on opportunities in both domestic and international markets, aiming to deliver stable returns to its investors and shareholders.

Investment Focus

• High-growth potential enterprises
• Introduction of advanced overseas technologies to the Chinese market
• Long-term value creation
• Flexibility in responding to global market changes

Portfolio Companies